Global Capacity Building for Global Challenges in Cardiovascular DiseaseGrobbeeDec 1, 201914(4): 345-346DownloadPDF (English)Dec 1, 201914(4): 345-346
Renal Disease is Associated with Poor Outcomes Following Isolated Coronary Artery Bypass GraftingAlramadan et al.Dec 1, 201914(4): 347-353DownloadPDF (English)Dec 1, 201914(4): 347-353
Effect of a Community Health Worker-Based Approach to Integrated Cardiovascular Risk Factor Control in India: A Cluster Randomized Controlled TrialKhetan et al.Dec 1, 201914(4): 355-365DownloadPDF (English)Dec 1, 201914(4): 355-365
Effects of HIV Infection on Pulmonary Artery Pressure in ChildrenIdris et al.Dec 1, 201914(4): 367-372DownloadPDF (English)Dec 1, 201914(4): 367-372
Long-Term Outcomes of a Cohort of Hypertensive Subjects in Rural EcuadorMoreira et al.Dec 1, 201914(4): 373-378DownloadPDF (English)Dec 1, 201914(4): 373-378
Association Between Perceived Neighborhood Characteristics and Carotid Artery Intima-Media Thickness: Cross-Sectional Results From the ELSA-Brasil StudyWillets et al.Dec 1, 201914(4): 379-385DownloadPDF (English)Dec 1, 201914(4): 379-385
Developing the Core Pillars of Training Global Cardiovascular Health Researchers: Companionship, Light, and FuelYan et al.Dec 1, 201914(4): 387-389DownloadPDF (English)Dec 1, 201914(4): 387-389
Strategic, Successful, and Sustained Synergy: The Global Alliance for Chronic Diseases Hypertension ProgramWebster et al.Dec 1, 201914(4): 391-394DownloadPDF (English)Dec 1, 201914(4): 391-394
Electrocardiographic Evidence of Cardiac Disease by Sex and HIV Serostatus in Mbarara, UgandaKentoffio et al.Dec 1, 201914(4): 395-397DownloadPDF (English)Dec 1, 201914(4): 395-397
Access to Essential Medicines for Circulatory Diseases: A Call to ActionMcKee et al.Dec 1, 201914(4): 399-400DownloadPDF (English)Dec 1, 201914(4): 399-400
Evaluating the World Heart Federation’s 25 by 25: The Forgotten MillionsVervoortDec 1, 201914(4): 401-402DownloadPDF (English)Dec 1, 201914(4): 401-402
